213 related articles for article (PubMed ID: 3326700)
1. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.
Rautaharju PM; Neaton JD
Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700
[TBL] [Abstract][Full Text] [Related]
2. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
[TBL] [Abstract][Full Text] [Related]
3. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
[TBL] [Abstract][Full Text] [Related]
4. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
[TBL] [Abstract][Full Text] [Related]
5. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study).
Rautaharju PM; Ge S; Nelson JC; Marino Larsen EK; Psaty BM; Furberg CD; Zhang ZM; Robbins J; Gottdiener JS; Chaves PH
Am J Cardiol; 2006 Feb; 97(3):309-15. PubMed ID: 16442387
[TBL] [Abstract][Full Text] [Related]
7. Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.
Holme I; Helgeland A; Hjermann I; Leren P; Lund-Larsen PG
JAMA; 1984 Mar; 251(10):1298-9. PubMed ID: 6366258
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic Minnesota code findings predicting short-term mortality in asymptomatic subjects. The Italian RIFLE Pooling Project (Risk Factors and Life Expectancy).
Menotti A; Seccareccia F
G Ital Cardiol; 1997 Jan; 27(1):40-9. PubMed ID: 9199942
[TBL] [Abstract][Full Text] [Related]
9. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of sudden death: insights from the Framingham Study.
Kannel WB; McGee DL
Cardiovasc Clin; 1985; 15(3):93-105. PubMed ID: 3833369
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.
Samuelsson O
Acta Med Scand Suppl; 1985; 702():1-79. PubMed ID: 3866485
[TBL] [Abstract][Full Text] [Related]
12. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
13. Nutrition in the Multiple Risk Factor Intervention Trial (MRFIT).
Farrand ME; Mojonnier L
J Am Diet Assoc; 1980 Apr; 76(4):347-51. PubMed ID: 7391467
[TBL] [Abstract][Full Text] [Related]
14. The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.
Reunanen A; Aromaa A; Pyörälä K; Punsar S; Maatela J; Knekt P
Acta Med Scand Suppl; 1983; 673():1-120. PubMed ID: 6578675
[TBL] [Abstract][Full Text] [Related]
15. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of prolonged ventricular repolarization in hypertension.
Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative.
Rautaharju PM; Kooperberg C; Larson JC; LaCroix A
Circulation; 2006 Jan; 113(4):473-80. PubMed ID: 16449726
[TBL] [Abstract][Full Text] [Related]
19. Electrocardiographic changes during exercise in asymptomatic men: 3-year follow-up.
Cumming GR; Samm J; Borysyk L; Kich L
Can Med Assoc J; 1975 Mar; 112(5):578-81. PubMed ID: 1116087
[TBL] [Abstract][Full Text] [Related]
20. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
Roderick PJ; Brennan PJ; Meade TW
J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
